Candesartan cilexetil
The name of the medicine is Kandesar. It contains the active substance candesartan cilexetil, which belongs to a group of medicines called angiotensin II receptor antagonists. It causes relaxation and dilation of blood vessels. This helps to lower blood pressure. It also makes it easier for the heart to pump blood to all parts of the body.
This medicine is used in:
Before starting to take Kandesar, the patient should discuss it with their doctor or pharmacist:
If the patient experiences stomach pain, nausea, vomiting, or diarrhea after taking Kandesar, they should discuss it with their doctor. The doctor will decide on further treatment. The patient should not stop taking Kandesar on their own.
Candesartan cilexetil has been studied in children. For more information, the patient should consult a doctor. Kandesar should not be given to children in the first year of life due to the potential risk to the developing kidneys.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
The doctor may need to change the dose and/or take other precautions:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
The doctor will usually recommend stopping Kandesar before planned pregnancy or as soon as pregnancy is confirmed, and recommend taking another medicine instead of Kandesar. It is not recommended to take Kandesar in early pregnancy and it should not be taken after the 3rd month of pregnancy, as it may seriously harm the fetus.
The patient should inform their doctor about breastfeeding or planning to breastfeed. It is not recommended to take Kandesar during breastfeeding. For patients planning to breastfeed, especially newborns or premature babies, the doctor may recommend taking another medicine.
In some people taking Kandesar, drowsiness or dizziness may occur. In such cases, the patient should not drive vehicles, use tools, or operate machines.
Kandesar 8 mg tablets contain 105.8 mg of lactose monohydrate, and 16 mg tablets contain 74.1 mg of lactose monohydrate. If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist. It is important to take Kandesar every day.
Kandesar can be taken with or without food.
The tablet should be swallowed with water.
The patient should try to take the tablets at the same time every day. This will help them remember to take them.
Children from 6 to 18 years of age: the recommended initial dose is 4 mg once a day.
Patients with a body weight of less than 50 kg: in patients who do not achieve adequate blood pressure control, the doctor may decide to increase the dose to a maximum of 8 mg once a day.
Patients with a body weight of 50 kg or more: in patients who do not achieve adequate blood pressure control, the doctor may decide to increase the dose to 8 mg once a day and then to 16 mg once a day.
The recommended initial dose of Kandesar is 4 mg once a day. The doctor may increase the dose by doubling it, at intervals of at least 2 weeks, to a dose of 32 mg once a day. Kandesar can be taken with other medicines used to treat heart failure; the doctor will decide which treatment is suitable for the patient.
In case of taking a higher dose of Kandesar than recommended, the patient should immediately contact their doctor or pharmacist for advice.
The patient should not take a double dose to make up for a missed tablet. They should take the next dose at the usual time.
If the patient stops taking Kandesar, their blood pressure may increase again. Therefore, the patient should not stop taking Kandesar without consulting their doctor first.
Like all medicines, Kandesar can cause side effects, although not everybody gets them.
It is important for the patient to know which side effects can occur.
Common ( may occur in up to 1 in 10 people):
Very rare ( may occur in up to 1 in 10,000 people):
In children treated for high blood pressure, side effects seem to be similar to those observed in adults, but they occur more frequently. Sore throat is a very common side effect in children, but it is not observed in adults. Also, runny nose, fever, and increased heart rate are common in children, but they are not observed in adults.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the label and carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Kandesar 8 mg tablets:
Uncoated tablets are pink to reddish-brown with a white speckling, round, biconvex, with a score line on one side and smooth on the other. The tablets can be divided into equal doses.
Kandesar 16 mg tablets:
Uncoated tablets are light pink to pale red, round, biconvex, with a score line on one side and smooth on the other. The tablets can be divided into equal doses.
Package sizes: 10, 14, 28, 30, 50, 56, 60, 98, and 100 tablets.
Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information on this medicine, the patient should contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Denmark, Finland, Norway, Sweden:
Candesartan Orion
Poland:
Kandesar
Date of last revision of the leaflet:20/01/2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.